Aim: to determine whether serum HER-2/neu level could be used as a prognostic factor in locally advanced breast cancer (LABC) and metastatic breast cancer (MBC). Methods: a prospective cohort study was done in LABC and MBC patients in dr. Sardjito Hospital Yogyakarta from April 2006 to March 2008. Serum concentration of HER-2/neu was measured by ELISA done before and after chemotherapy. HER-…
Background: As the world rates of breast cancer have increased, there has been a growing awareness of psychological effect of diagnosis and treatment and its role in the outcome of chronic disorders. Radiotherapy for breast cancer is an intense and cyclic treatment associated with number of side-effects. The sociodemographic factors of age, gender, marital status, education, immigrant status, i…